← Back to catalog

RxHero - Master Top 250 Drugs

Mobile Appmicrooff marketMedicalvia App Store
A one-page read: the numbers, the trend, valuation, and how to approach the owner.
ratings
26
Rating
4 / 5
Estimated valuation vs comps

Comparable Mobile App this size sell around 3.4x annual profit (2.1 to 5x, 118 comps).

Key facts
Developer
ClinCalc LLC
Genre
Medical
Ratings
26
Price
$2.99
Version
2.0

Off-market target. Not listed for sale, so there are no public financials. The play is to approach the owner directly.

About

RxHero is an educational game for healthcare students and professionals to learn the top 250 medications in the outpatient setting (also known as the Top 200 Drugs or Top 300 Drugs). RxHero uses a multi-modal, adaptive learning approach with quizzes, matching, and drug spelling combined with a gamification component with quests, campaigns, points, and rankings as you progress through the app. This app is perfect for pharmacists, pharmacy technicians, physician assistants, nurses, nursing students, physicians, medical students, and other healthcare professionals. The drug database is designed to aid in studying for both students in school and those preparing for standardized exams (eg, NAPLEX, BCPS, PTCB, ExCPT, PANCE/PANRE, NCLEX, USMLE, COMLEX). == FEATURES == • Content includes brand/generic names, drug class, indications, common/rare adverse effects, boxed warnings, counseling pearls, notable drug interactions, and mechanism of action • Assess your drug therapy knowledge using multiple-choice quizzes, term matching, and drug name spelling • Adaptive (Leitner) learning mode focuses on drug facts that you haven't mastered yet to optimize your study time • On-demand drug pronunciations are embedded throughout the app • Contains the top 250 of the most common outpatient medications based on the ClinCalc DrugStats database (version 19.1) == GAMIFICATION == • Motivate your learning with a unique "gamification" component • Earn points for answering correctly and bonus points

Traffic, trend, size, and valuation figures here are estimates, not verified by the seller. Always do your own diligence before reaching out or making an offer.